Shandong Weifang Rainbow Chemical Co., Ltd. Class A

Shandong Weifang Rainbow Chemical Co., Ltd. Class A

SSZSE:301035
41.15
CNY
-0.10
(-0.24%)
2.77EPS
20.74P/E
18.04BMarket Cap
Apr 23Next Earn
2013 Y
2014 Y
2015 Y
2016 Y
2017 Y
2018 Y
2019 Y
2020 Y
2021 Y
2022 Y
2023 Y
2024 Y
2025 Y
TTM
Revenue per Share
11.78
13.23
12.46
16.22
18.99
20.08
22.58
27.04
31.95
40.3
31.85
36.59
40.56
42.12
Basic EPS, GAAP
1.22
0.63
0.77
1.02
0.98
1.15
1.26
1.62
2.61
3.94
2.14
1.24
2.88
2.39
Free Cash Flow per Basic Share
0.01
0.01
1.24
1.51
0.57
1.08
1.93
0.7
0.58
2.16
-5.52
-0.24
3.33
- -
Dividend per Share
0.21
0.24
0.23
0.34
0.3
0.24
0.27
0.35
0.53
0.71
1.4
1.26
0.86
1.65
Book Value per Share
3.67
4.15
4.8
5.56
7
7.99
9.1
10.41
13.67
17.17
18.07
18.25
20.68
20.95
Tangible Book Value per Share
3.6
4.09
4.37
5.01
6.44
7.44
8.54
9.86
13.27
16.27
17.12
16.64
18.38
18.28
Basic Weighted Avg Shares
234
233
233
234
266
269
269
270
307
359
361
363
362
363
Sales/Revenue/Turnover
2,757
3,077
2,907
3,802
5,047
5,402
6,074
7,290
9,797
14,460
11,485
13,296
14,688
15,287
Operating Margin (%)
13.48
7.35
7.66
9.73
11.05
8.77
7.47
8.73
10.56
13.3
10.14
9.05
12.09
13.49
Depreciation Expense
51
71
78
87
88
89
106
106
142
183
257
321
362
- -
Net Income, GAAP
286
147
179
238
262
310
339
438
800
1,413
771
450
1,045
866
Effective Tax Rate (%)
13.75
22.8
24.99
21.75
27.31
15.3
16.53
15.12
14.49
15.12
9.6
- -
19.35
19.26
Profit Margin (%)
10.39
4.77
6.17
6.26
5.18
5.75
5.59
6
8.16
9.77
6.71
3.39
7.11
5.67
Working Capital
296
251
323
545
1,054
1,307
1,513
1,681
3,295
3,898
3,987
3,708
3,957
3,462
LT Debt
- -
- -
- -
- -
- -
- -
- -
53
39
26
86
377
271
116
Total Equity
860
974
1,155
1,360
1,964
2,234
2,553
2,928
5,043
6,387
6,840
7,049
7,978
8,163
Return on Invested Capital (%)
- -
10.33
11.06
13.81
14.73
16.26
17.27
17.09
19.03
24.47
10.85
- -
12.4
- -
Return on Capital (%)
- -
11.24
10.26
12.77
14.41
15.53
15.49
13.65
16.71
21.77
9.36
- -
9.82
- -
Return on Common Equity (%)
- -
16.04
17.14
19.64
16.42
15.38
14.75
16.67
20.74
25.48
12.11
6.82
14.7
- -

Capital Structure

CNY

•

in mil. unless spec.
Mar'26
Jun'26
Sep'26
ST Debt
2,741
3,123
2,879
LT Borrowings
281
107
62
LT Finance Leases
49
51
54
Preferred Equity and Hybrid Capital
- -
- -
- -
Shares Outstanding
365
365
365
Market Capitalization
21,406
16,913
18,043

Working Capital

CNY

•

in mil. unless spec.
Mar'26
Jun'26
Sep'26
Total Current Assets
12,974
14,094
13,668
Cash, Cash Equivalents & STI
3,348
4,105
4,144
Accounts Receivable, Net
5,409
5,354
5,250
Inventories
3,528
3,958
3,537
Total Current Liabilities
8,945
10,407
10,206
Payables & Accruals
- -
- -
- -
ST Debt
2,741
3,123
2,879
Deferred Revenue
- -
- -
- -

Growth Rates

CNY

•

in mil. unless spec.

(avg. rate of change)

10 years
5 years
1 year
Total Equity
22.71%
24.45%
13.17%
Free Cash Flow
-155.53%
-325.7%
-1,507.49%
Net Income, GAAP
30.4%
40.89%
132.07%
Sales/Revenue/Turnover
19.07%
17.53%
10.47%
Total Cash Common Dividend
26.09%
37.27%
-31.97%

Quarterly Revenue

CNY

•

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2024
2,693
2,989
4,103
3,511
13,296
2025
2,686
3,844
- -
3,777
14,688
2026
3,191
4,250
4,069
- -
- -

Quarterly Earnings Per Share

CNY

•

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2024
0.42
0.08
0.44
0.3
1.24
2025
0.7
0.83
- -
0.43
2.88
2026
0.45
0.93
0.58
- -
- -

Quarterly Dividends Per Share

CNY

•

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2024
0.07
0.86
0.17
0.17
1.26
2025
0.05
0.39
- -
0.02
0.86
2026
0.03
1.06
0.54
- -
- -

Company Description

CEO
Jie Shen
Full Time Employees
5,109
Sector
Process industries
Industry
Chemicals: agricultural
Address
Jinan China
IPO Date
Jul 28, 2021
Business
Shandong Weifang Rainbow Chemical Co., Ltd. (SZSE: 301035), operating internationally as Rainbow Agro, is a China-based crop protection enterprise engaged in the research, development, synthesis, formulation, registration, and global marketing of agrochemical products and agricultural inputs. Founded in 2000 and headquartered in Weifang, Shandong Province, China, the company operates across key international agricultural markets spanning Latin America, North America, Europe, the Asia-Pacific, the Middle East, and Africa, supported by manufacturing and formulation facilities in China, Spain, the United States, and Argentina. The company offers a comprehensive portfolio of crop protection solutions, technical-grade active ingredients, and branded formulations categorized into: herbicides, including glyphosate, glufosinate-ammonium, flumioxazin, 2,4-D, atrazine, clethodim, and mesotrione; fungicides, including azoxystrobin, tebuconazole, mancozeb, chlorothalonil, and difenoconazole; insecticides and acaricides, including imidacloprid, thiamethoxam, emamectin benzoate, and lambda-cyhalothrin; plant growth regulators and seed treatments; biological solutions under the Rainbow Bio brand, including bio-pesticides, biostimulants, and specialty plant nutrition; custom formulation services utilizing delivery systems such as water-dispersible granules (WDG), suspension concentrates (SC), soluble liquids (SL), and emulsifiable concentrates (EC); as well as global regulatory registration management, contract manufacturing, and localized supply chain distribution services. In recent operational and strategic developments, the company has expanded its manufacturing and logistics infrastructure in North America by establishing formulation production capabilities near Houston, Texas, and Champaign, Illinois. In June 2024, the company entered into a global strategic alliance with Hebang Biotechnology to distribute and market glyphosate products worldwide. In October 2024, the company introduced Rainbow Bio, a dedicated business division focused on the commercialization of biological crop protection and nutrition products across global markets. Furthermore, building on its European expansion following the acquisition of Spain-based Exclusivas Sarabia S.A., the company invested approximately RMB 260 million into expanding active ingredient synthesis capacities, including a 1,000-metric-ton flumioxazin manufacturing facility, while continuing to expand its overseas direct-sales channels and regulatory registration asset base.